Cargando…
Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations
Botulinum neurotoxins (BoNT) are considered some of the most lethal known substances. There are seven botulinum serotypes, of which types A, B and E cause most human botulism cases. Anti-botulinum polyclonal antibodies (PAbs) are currently used for both detection and treatment of the disease. Howeve...
Autores principales: | Diamant, Eran, Lachmi, Bat-El, Keren, Adi, Barnea, Ada, Marcus, Hadar, Cohen, Shoshana, David, Alon Ben, Zichel, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903612/ https://www.ncbi.nlm.nih.gov/pubmed/24475231 http://dx.doi.org/10.1371/journal.pone.0087089 |
Ejemplares similares
-
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations
por: Torgeman, Amram, et al.
Publicado: (2017) -
Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021) -
High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding Domain
por: Ben David, Alon, et al.
Publicado: (2022) -
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
por: Diamant, Eran, et al.
Publicado: (2015) -
Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
por: Rosen, Osnat, et al.
Publicado: (2016)